Marker AG
PrivateMomentum
Top 25%
of companies Caplight tracks
Company Overview
Marker AG is a biotechnology company that develops non-invasive diagnostic tools and therapeutic devices for medical conditions including traumatic brain injuries and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Marker AG Comparables
Compare Marker AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HeadFirst Inc. | 82% | |
| Medicortex Finland | 80% | |
| RapidDx | 79% | |
Marker AG Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Grew 22% QoQ, from 18 to 22 employees.
- Jan 22, 2026
Monthly visitors increased 201% MoM, from 304 to 916.
Marker AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Marker AG's valuation, stock price, and market status.